The National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services, awarded a $10,326.95 firm-fixed-price purchase order contract to Meso Scale Diagnostics, LLC (doing business as Meso Scale Discovery) to supply MSD kits for running high-throughput detection and quantification of neutrophil biomarkers to support a dengue study. This contract has no set-aside designation and is for completion by April 7, 2025. Meso Scale Diagnostics is a for-profit limited liability company that specializes in assay development, testing equipment, and immunoassay products for biomedical research and diagnostics. The company has extensive experience supporting federal agencies through prime contracts, subcontracts, and grants, including work related to COVID-19 response efforts.
Generated 2/25/25, 10:06 AM